Directorate Change
CRISM Therapeutics Corporation announces the resignation of Dr. Nermeen Varawalla from the Board of Directors, who served as Non-Executive Chair since the company's AIM listing in May 2024. Andrew Webb will continue as Interim Executive Chair while a search for a successor is underway, with Gerry Beaney taking over as Chair of the Remuneration Committee. The company expressed gratitude for Dr. Varawalla's contributions and noted that the search for a new Chair aligns with CRISM's progression towards its phase 2 clinical trial and future commercialisation.
Select text to share a quote on X · sign in to keep highlights & notes in your CRTX notes
596/2014, as incorporated into UK law by the European Union (Withdrawal) Act 2018.
CRISM Therapeutics Corporation
('CRISM', 'CRISM Therapeutics' or the 'Company')
Board Changes
CRISM Therapeutics Corporation (AIM: CRTX), a UK clinical-stage drug delivery company focused on the localised and sustained delivery of chemotherapy drugs, announces that Dr Nermeen Varawalla has resigned from the Board of Directors in order to pursue other professional interests. Nermeen was appointed Non-Executive Chair at the Company's Admission to AIM in May 2024 and, as previously announced, in October 2025 stepped back from her role.
Andrew Webb will continue to act as Executive Chair on an interim basis until a new Chair is identified. Gerry Beaney, Independent Non-Executive Director and Chair of the Audit Committee will chair the Remuneration Committee.
Andrew Webb, Interim Exec Chair, said: "The Company wishes to thank Nermeen for her valuable contribution to CRISM since our AIM listing in May 2024 and we wish her well with her future endeavours. A search for a successor with the requisite skills and experience as CRISM progresses towards its phase 2 clinical trial and future commercialisation is underway. We will update the market as to its progress in due course."
The Company's LEI is 213800XFW6MKVCHHPW88.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.